Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition
Clinics
;
67(7): 761-765, July 2012. ilus, tab
Artículo
en Inglés
| LILACS
| ID: lil-645448
ABSTRACT
OBJECTIVE:
The association between renal hypoxia and the development of renal injury is well established. However, no adequate method currently exists to non-invasively measure functional changes in renal oxygenation in normal and injured patients.METHOD:
R2* quantification was performed using renal blood oxygen level-dependent properties. Five healthy normotensive women (50±5.3 years) underwent magnetic resonance imaging in a 1.5T Signa Excite HDx scanner (GE Healthcare, Waukesha, WI). A multiple fast gradient-echo sequence was used to acquire R2*/T2* images (sixteen echoes from 2.1 ms/slice to 49.6 ms/slice in a single breath hold per location). The images were post-processed to generate R2* maps for quantification. Data were recorded before and at 30 minutes after the oral administration of an angiotensin II-converting enzyme inhibitor (captopril, 25 mg). The results were compared using an ANOVA for repeated measurements (mean + standard deviation) followed by the Tukey test. ClinicalTrials.gov NCT01545479.RESULTS:
A significant difference (p<0.001) in renal oxygenation (R2*) was observed in the cortex and medulla before and after captopril administration right kidney, cortex = 11.08 ± 0.56ms, medulla = 17.21 ± 1.47ms and cortex = 10.30 ± 0.44ms, medulla = 16.06 ± 1.74ms, respectively; and left kidney, cortex= 11.79 ± 1.85ms, medulla = 17.03 ± 0.88ms and cortex = 10.89 ± 0.91ms, medulla = 16.43 ± 1.49ms, respectively.CONCLUSIONS:
This result suggests that the technique efficiently measured alterations in renal blood oxygenation after angiotensin II-converting enzyme inhibition and that it may provide a new strategy for identifying the early stages of renal disease and perhaps new therapeutic targets.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Oxígeno
/
Inhibidores de la Enzima Convertidora de Angiotensina
/
Captopril
/
Riñón
Tipo de estudio:
Estudio pronóstico
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Clinics
Asunto de la revista:
Medicina
Año:
2012
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
FUC)+BR
/
MR Res Latin America GE Healthcare/BR
/
Servico de Investigação Diagnóstica (SIDI)/BR
/
Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)/BR
Similares
MEDLINE
...
LILACS
LIS